![](/cdn/assets/images/search/clock.png)
We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
Manzo Pharmaceuticals Inc (CE) | USOTC:MNZO | OTCMarkets | Common Stock |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 0.000001 | 0.00 | 00:00:00 |
The property is located in the Slocan area of B.C. within easy commuting distance of both Kaslo and New Denver. A gravel road extends north to allow access to area over the whole field season.
Previous exploration in the area on and around the claims resulted in numerous discoveries, one of the largest being the Whitewater Mine. The subject mine, located just to the north of the property, produced 260,542 tons of ore containing 1435 oz gold, 3,152,130 oz silver, 28,017,903 lbs lead and 6,260,370 lbs zinc during the period from 1892 to 1945 for an average of 12 oz/ton silver, 5.4% lead and 1.2% zinc. The ore bodies were found adjacent to a thrust fault zone within slate and limestone of the Slocan Group (Hedley 1945).
The whole region is well known for its exceptional high grade mineralization that follows the general structural trend of 310 degrees, dipping generally southwesterly encountering similar grades over the mineralized area. Reports done in the past, underline the possibility that the economically viable area of mineralization could be extended further from the deposits that were exploited in the past.
FOGC management affirms its dedication to its current mining and oil exploration subsidiaries, (Cressent Energy and Alta Mining), and the majority shareholders financial backing of these various announced projects will achieve the projected company growth.
In other company news and events, the company is awaiting a National Instrument 43-101 to complete a compilation report which will be shared with followers in due time. More details will follow shortly.
Safe Harbor Statement
Information in this news release may contain statements about future expectations, plans, prospects or performance of Fortune Oil & Gas, Inc., that constitute forward-looking statements for purposes of the Safe Harbor Provisions under the Private Securities Litigation Reform Act of 1995. The words or phrases "can be," "expects," "may affect," "believed," "estimate," "project" and similar words and phrases are intended to identify such forward-looking statements. Fortune Oil & Gas, Inc. cautions you that any forward-looking information provided by or on behalf of Fortune Oil & Gas, Inc. is not a guarantee of future performance. None of the information in this press release constitutes or is intended as an offer to sell securities or investment advice of any kind. Fortune Oil & Gas, Inc.'s actual results may differ materially from those anticipated in such forward-looking statements as a result of various important factors, some of which are beyond Fortune Oil & Gas, Inc.'s control. In addition to those discussed in Fortune Oil & Gas, Inc.'s press releases, public filings, and statements by Fortune Oil & Gas, Inc.'s management, including, but not limited to, Fortune Oil & Gas, Inc.'s estimate of the sufficiency of its existing capital resources, Fortune Oil & Gas, Inc.'s ability to raise additional capital to fund future operations, Fortune Oil & Gas, Inc.'s ability to repay its existing indebtedness, the uncertainties involved in estimating market opportunities, and in identifying contracts which match Fortune Oil & Gas, Inc.'s capability to be awarded contracts. All such forward-looking statements are current only as of the date on which such statements were made. Fortune Oil & Gas, Inc. does not undertake any obligation to publicly update any forward-looking statement to reflect events or circumstances after the date on which any such statement is made or to reflect the occurrence of unanticipated events.
Fortune Oil & Gas, Inc.
Contacts: Investor Relations 1-647-426-1640 www.minamargroup.net/helpdesk Investor Relations Department Inquiries www.minamargroup.net For M&A and Corporate Matters www.minamargroup.com
1 Year Manzo Pharmaceuticals (CE) Chart |
1 Month Manzo Pharmaceuticals (CE) Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions